Supernus Pharmaceuticals Inc (SUPN) — Financial Flexibility Index
Supernus Pharmaceuticals Inc (SUPN) has a Financial Flexibility Index of -0.01x as of June 2026. Free cash flow of $-4.24 Million (operating CF $-4.81 Million minus capex $568.00K) represents 0% of total liabilities ($396.88 Million). Check Supernus Pharmaceuticals Inc total reinvestment intensity to assess the company's total reinvestment commitment from operating cash flow.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Supernus Pharmaceuticals Inc Financial Flexibility Index (2008–2025)
Historical Financial Flexibility Index trend for Supernus Pharmaceuticals Inc across 18 annual periods. For the full cash flow conversion analysis, see Supernus Pharmaceuticals Inc operating cash flow efficiency.
Annual Financial Flexibility Index for Supernus Pharmaceuticals Inc (2008–2025)
Year-by-year free cash flow to debt coverage for Supernus Pharmaceuticals Inc. Explore cash flow to debt ratio of Supernus Pharmaceuticals Inc to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.12x | $48.67 Million | $47.33 Million | $390.93 Million | ▼ -76.0% |
| 2024 | 0.52x | $172.68 Million | $171.95 Million | $332.34 Million | ▲ +65.8% |
| 2023 | 0.31x | $111.64 Million | $111.08 Million | $356.16 Million | ▲ +118.2% |
| 2022 | 0.14x | $117.24 Million | $116.83 Million | $816.30 Million | ▼ -2.9% |
| 2021 | 0.15x | $129.17 Million | $127.13 Million | $873.30 Million | ▼ -20.8% |
| 2020 | 0.19x | $141.85 Million | $138.40 Million | $759.24 Million | ▼ -27.7% |
| 2019 | 0.26x | $145.87 Million | $143.13 Million | $564.85 Million | ▲ +4.4% |
| 2018 | 0.25x | $129.83 Million | $128.99 Million | $524.79 Million | ▼ -66.7% |
| 2017 | 0.74x | $116.67 Million | $114.64 Million | $156.98 Million | ▲ +28.0% |
| 2016 | 0.58x | $68.42 Million | $66.81 Million | $117.81 Million | ▲ +18.5% |
| 2015 | 0.49x | $34.23 Million | $32.12 Million | $69.86 Million | ▲ +289.3% |
| 2014 | 0.13x | $8.33 Million | $7.73 Million | $66.15 Million | ▲ +117.6% |
| 2013 | -0.72x | $-55.60 Million | $-57.95 Million | $77.53 Million | ▲ +43.8% |
| 2012 | -1.28x | $-46.45 Million | $-47.20 Million | $36.42 Million | ▼ -59.1% |
| 2011 | -0.80x | $-35.50 Million | $-36.19 Million | $44.29 Million | ▼ -127.0% |
| 2010 | -0.35x | $-32.25 Million | $-32.54 Million | $91.33 Million | ▼ -1007.6% |
| 2009 | 0.04x | $3.35 Million | $2.63 Million | $86.06 Million | ▲ +111.1% |
| 2008 | -0.35x | $-29.52 Million | $-29.65 Million | $83.88 Million | — |